Avanos Medical, Inc. (NYSE:AVNS) Q2 2019 Results Conference Call August 6, 2019 9:00 AM ET Company Participants Dave Crawford – Vice President of Investor Relations Joe Woody – Chief Executive Officer Conference Call Participants Rick Wise – Stifel Ravi Misra – Berenberg Capital Markets Larry Keusch – Raymond James Matthew Mishan – KeyBanc David Lewis – Morgan Stanley Chris Cooley – Stephens Kristen Stewart – Barclays Operator Good day and welcome to the Avanos Second Quarter Earnings Conference Call and We ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-36440 AVANOS MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 46-4987888 (State or o ...

Avanos Medical, Inc. (NYSE:AVNS) Q1 2019 Earnings Conference Call May 7, 2019 9:00 AM ET Company Participants David Crawford - VP, FP&A and IR and Treasurer Joseph Woody - CEO & Director Steven Voskuil - SVP & CFO Conference Call Participants Lawrence Keusch - Raymond James & Associates Ravi Misra - Berenberg Frederick Wise - Stifel, Nicolaus & Company Jonathan Demchick - Morgan Stanley Kristen Stewart - Barclays Bank Matthew Mishan - KeyBanc Capital Markets Christopher Cooley - Stephens Inc. Operator Good ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-36440 AVANOS MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 46-4987888 (State o ...

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 UNITED STATES FORM 10-K (Mark One) x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2018 OR o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number: 001-36440 Avanos Medical, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation) (I. ...